CBD Product Safety and Standardization Act of 2023

Hemp-Derived Cannabidiol (CBD) regulations and legislation Monitor the following: S.5243, Cannabinoid Safety and Regulation Act of 2024, Entirety Regulatory enforcement of dietary supplements, Mandatory product registration issues Hemp Access and Consumer Safety H.R.8467, Farm, Food, and National Security Act of 2024, National Organic Program related issues H.R.1628, To authorize the regulation of interstate commerce with respect to food containing cannabidiol derived from hemp, and for other purposes, Entirety H.R.1629, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023, Entirety

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES

H.R. 1628, H.R. 1629, S. 2451, Regulation of CBD as dietary supplement and food additive, Farm Bill

Client expense: Not reported · Firm income: $80,000

Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

Medicare and Medicaid Programs: Minimum Staffing Standards for Long-Term Care Facilities and Medicaid Institutional Payment Transparency Reporting (CMS 3442-P) ARPA American Rescue Act Plan Funding OSHA Covid-19 Health Care Emergency Temporary Standard (ETS) Bill That Extends Moratorium on 2% Medicare Sequester Cuts Through End of 2021 Healthcare Price Transparency Rules for Hospitals 340B Medicare DSH Medicare Physician Payment (MACRA) H.R. 365 The Primary Care Enhancement Act S. 898/H.R. 2141 Conrad State 30 and Physician Access Reauthorization Act S. 1130 Rural Emergency Acute Care Hospital (REACH) Act S. 257 / H.R. 1611: Protecting Access to Rural Therapy Services Act S. 258 / H.R. 169: Critical Access Hospital Relief Act of 2015 H.R. 672 / S. 607: Rural Community Hospital Demonstration Extension Act of 2015 S. 1135: Hospital Payment Fairness Act H.R. 1479: Repeal of the Obamacare Bay State Boondoggle Act S. 1648: Rural Emergency Acute Care Hospital Act H.R. 3225: Save Rural Hospitals Act H.R. 1343 / S. 688: Establishing Beneficiary Equity in the Hospital Readmission Program Act S. 1148 / H.R. 2124: Resident Physician Shortage Reduction Act S. 2484 / H.R. 4442: CONNECT for Health Act H.R. 2156: Medicare Audit Improvement Act H.R. 5164: Rural Hospital Regulatory Relief Act S. 3435: Craig Thomas Rural Hospital and Provider Equity Act of 2016 H.R. 5406: Helping Ensure Accountability, Leadership, and Trust in Tribal Healthcare Act H.R. 34: 21st Century Cures Act H.R. 3298: Medicare Post-Acute Care Value-Based Purchasing Act H.R 1628: American Health Care Act S. 872 / H.R. 1955: Rural Hospital Access Act S. 377: Medicare Ambulance Access, Fraud Prevention and Reform Act H.R. 1156: Patient Access to Higher Quality Health Care Act of 2017 H.R. 2: Medicare Access and CHIP Reauthorization Act of 2016 H.R. 1628 Better Care Reconciliation Act (BCRA) H.R. 4392 To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes. The Senate Committee on Health, Education, Labor and Pensions (HELP) June 26 passed the Lower Health Care Costs Act of 2019 (S.1895) Congress should act now to delay the Medicaid DSH cuts that are scheduled to go into effect Nov. 22. The Coronavirus Aid, Relief, and Economic Security (CARES) Act.

H.R. 1628, H.R. 1629, S. 2451, Regulation of CBD as dietary supplement and food additive, Farm Bill

Client expense: Not reported · Firm income: $80,000

Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

Issues related to dietary supplements H.R.1629, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023 H.R.1628 CBD Product Safety and Standardization Act of 2023 FDA Reorganization H.R.4794 Dietary Supplements Access Act Mandatory Product Listing

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1628, CBD Product Safety and Standardization Act of 2023.

Client expense: $290,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Potential amendments related to dietary supplements in HELP Committee legislation being developed with respect to pharmaceutical pricing and consumer access (S 1339, pharmacy Benefit Manger Reform Act) Legislation including provisions to allow and clarify Food and Drug Administration regulation of hemp-derived/CBD products (HR 1629, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act, S 2451, the Cannabinoid Safety and Regulation Act; HR 1628, the CBD Product Safety and Standardization Act).

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.5243, Cannabinoid Safety and Regulation Act of 2024, Entirety Regulatory enforcement of dietary supplements, Mandatory product registration issues Hemp-Derived Cannabidiol (CBD) regulations Monitor the following: Hemp Access and Consumer Safety H.R.8467, Farm, Food, and National Security Act of 2024, National Organic Program related issues H.R.1628, To authorize the regulation of interstate commerce with respect to food containing cannabidiol derived from hemp, and for other purposes, Entirety H.R.1629, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023, Entirety

Client expense: Not reported · Firm income: $10,000

Government targets: SENATE

Medicare and Medicaid Programs: Minimum Staffing Standards for Long-Term Care Facilities and Medicaid Institutional Payment Transparency Reporting (CMS 3442-P) ARPA American Rescue Act Plan Funding OSHA Covid-19 Health Care Emergency Temporary Standard (ETS) Bill That Extends Moratorium on 2% Medicare Sequester Cuts Through End of 2021 Healthcare Price Transparency Rules for Hospitals 340B Medicare DSH Medicare Physician Payment (MACRA) H.R. 365 The Primary Care Enhancement Act S. 898/H.R. 2141 Conrad State 30 and Physician Access Reauthorization Act S. 1130 Rural Emergency Acute Care Hospital (REACH) Act S. 257 / H.R. 1611: Protecting Access to Rural Therapy Services Act S. 258 / H.R. 169: Critical Access Hospital Relief Act of 2015 H.R. 672 / S. 607: Rural Community Hospital Demonstration Extension Act of 2015 S. 1135: Hospital Payment Fairness Act H.R. 1479: Repeal of the Obamacare Bay State Boondoggle Act S. 1648: Rural Emergency Acute Care Hospital Act H.R. 3225: Save Rural Hospitals Act H.R. 1343 / S. 688: Establishing Beneficiary Equity in the Hospital Readmission Program Act S. 1148 / H.R. 2124: Resident Physician Shortage Reduction Act S. 2484 / H.R. 4442: CONNECT for Health Act H.R. 2156: Medicare Audit Improvement Act H.R. 5164: Rural Hospital Regulatory Relief Act S. 3435: Craig Thomas Rural Hospital and Provider Equity Act of 2016 H.R. 5406: Helping Ensure Accountability, Leadership, and Trust in Tribal Healthcare Act H.R. 34: 21st Century Cures Act H.R. 3298: Medicare Post-Acute Care Value-Based Purchasing Act H.R 1628: American Health Care Act S. 872 / H.R. 1955: Rural Hospital Access Act S. 377: Medicare Ambulance Access, Fraud Prevention and Reform Act H.R. 1156: Patient Access to Higher Quality Health Care Act of 2017 H.R. 2: Medicare Access and CHIP Reauthorization Act of 2016 H.R. 1628 Better Care Reconciliation Act (BCRA) H.R. 4392 To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes. The Senate Committee on Health, Education, Labor and Pensions (HELP) June 26 passed the Lower Health Care Costs Act of 2019 (S.1895) Congress should act now to delay the Medicaid DSH cuts that are scheduled to go into effect Nov. 22. The Coronavirus Aid, Relief, and Economic Security (CARES) Act.

Issues related to dietary supplements H.R.1629, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023 H.R.1628 CBD Product Safety and Standardization Act of 2023 FDA Reorganization H.R.4794 Dietary Supplements Access Act Mandatory Product Listing

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1628, CBD Product Safety and Standardization Act of 2023.

Client expense: $590,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Hemp Access and Consumer Safety Farm Bill of 2024, National Organic Program related issues Monitor the following: H.R.1628, To authorize the regulation of interstate commerce with respect to food containing cannabidiol derived from hemp, and for other purposes, Entirety H.R.1629, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023, Entirety Regulatory enforcement of dietary supplements, Mandatory product registration issues Cosmetics Regulatory Reform, Implementation related issues Hemp-Derived Cannabidiol (CBD) regulations

Client expense: Not reported · Firm income: $20,000

Government targets: SENATE

Medicare and Medicaid Programs: Minimum Staffing Standards for Long-Term Care Facilities and Medicaid Institutional Payment Transparency Reporting (CMS 3442-P) ARPA American Rescue Act Plan Funding OSHA Covid-19 Health Care Emergency Temporary Standard (ETS) Bill That Extends Moratorium on 2% Medicare Sequester Cuts Through End of 2021 Healthcare Price Transparency Rules for Hospitals 340B Medicare DSH Medicare Physician Payment (MACRA) H.R. 365 The Primary Care Enhancement Act S. 898/H.R. 2141 Conrad State 30 and Physician Access Reauthorization Act S. 1130 Rural Emergency Acute Care Hospital (REACH) Act S. 257 / H.R. 1611: Protecting Access to Rural Therapy Services Act S. 258 / H.R. 169: Critical Access Hospital Relief Act of 2015 H.R. 672 / S. 607: Rural Community Hospital Demonstration Extension Act of 2015 S. 1135: Hospital Payment Fairness Act H.R. 1479: Repeal of the Obamacare Bay State Boondoggle Act S. 1648: Rural Emergency Acute Care Hospital Act H.R. 3225: Save Rural Hospitals Act H.R. 1343 / S. 688: Establishing Beneficiary Equity in the Hospital Readmission Program Act S. 1148 / H.R. 2124: Resident Physician Shortage Reduction Act S. 2484 / H.R. 4442: CONNECT for Health Act H.R. 2156: Medicare Audit Improvement Act H.R. 5164: Rural Hospital Regulatory Relief Act S. 3435: Craig Thomas Rural Hospital and Provider Equity Act of 2016 H.R. 5406: Helping Ensure Accountability, Leadership, and Trust in Tribal Healthcare Act H.R. 34: 21st Century Cures Act H.R. 3298: Medicare Post-Acute Care Value-Based Purchasing Act H.R 1628: American Health Care Act S. 872 / H.R. 1955: Rural Hospital Access Act S. 377: Medicare Ambulance Access, Fraud Prevention and Reform Act H.R. 1156: Patient Access to Higher Quality Health Care Act of 2017 H.R. 2: Medicare Access and CHIP Reauthorization Act of 2016 H.R. 1628 Better Care Reconciliation Act (BCRA) H.R. 4392 To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes. The Senate Committee on Health, Education, Labor and Pensions (HELP) June 26 passed the Lower Health Care Costs Act of 2019 (S.1895) Congress should act now to delay the Medicaid DSH cuts that are scheduled to go into effect Nov. 22. The Coronavirus Aid, Relief, and Economic Security (CARES) Act.

H.R. 1628, H.R. 1629, S. 2451, Regulation of CBD as dietary supplement and food additive, Farm Bill

Client expense: Not reported · Firm income: $80,000

Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

Issues related to dietary supplements H.R.1629, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023 H.R.1628 CBD Product Safety and Standardization Act of 2023 FDA Reorganization H.R.4794 Dietary Supplements Access Act Mandatory Product Listing

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1628, CBD Product Safety and Standardization Act of 2023.

Client expense: $330,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.1628, To authorize the regulation of interstate commerce with respect to food containing cannabidiol derived from hemp, and for other purposes, Entirety H.R.1629, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023, Entirety S.2451, Hemp Access and Consumer Safety Act, Entirety Monitor the following: Farm Bill of 2024, National Organic Program related issues Regulatory enforcement of dietary supplements, Mandatory product registration issues Cosmetics Regulatory Reform, Implementation related issues Hemp-Derived Cannabidiol (CBD) regulations

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1628, H.R. 1629, S. 2451, Regulation of CBD as dietary supplement and food additive, 2023 Farm Bill

Client expense: Not reported · Firm income: $80,000

Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

HR 1628 - CBD Product Safety and Standardization Act of 2023; all provisions of the bill HR 1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023; all provisions of the bill

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

Medicare and Medicaid Programs: Minimum Staffing Standards for Long-Term Care Facilities and Medicaid Institutional Payment Transparency Reporting (CMS 3442-P) ARPA American Rescue Act Plan Funding OSHA Covid-19 Health Care Emergency Temporary Standard (ETS) Bill That Extends Moratorium on 2% Medicare Sequester Cuts Through End of 2021 Healthcare Price Transparency Rules for Hospitals 340B Medicare DSH Medicare Physician Payment (MACRA) H.R. 365 The Primary Care Enhancement Act S. 898/H.R. 2141 Conrad State 30 and Physician Access Reauthorization Act S. 1130 Rural Emergency Acute Care Hospital (REACH) Act S. 257 / H.R. 1611: Protecting Access to Rural Therapy Services Act S. 258 / H.R. 169: Critical Access Hospital Relief Act of 2015 H.R. 672 / S. 607: Rural Community Hospital Demonstration Extension Act of 2015 S. 1135: Hospital Payment Fairness Act H.R. 1479: Repeal of the Obamacare Bay State Boondoggle Act S. 1648: Rural Emergency Acute Care Hospital Act H.R. 3225: Save Rural Hospitals Act H.R. 1343 / S. 688: Establishing Beneficiary Equity in the Hospital Readmission Program Act S. 1148 / H.R. 2124: Resident Physician Shortage Reduction Act S. 2484 / H.R. 4442: CONNECT for Health Act H.R. 2156: Medicare Audit Improvement Act H.R. 5164: Rural Hospital Regulatory Relief Act S. 3435: Craig Thomas Rural Hospital and Provider Equity Act of 2016 H.R. 5406: Helping Ensure Accountability, Leadership, and Trust in Tribal Healthcare Act H.R. 34: 21st Century Cures Act H.R. 3298: Medicare Post-Acute Care Value-Based Purchasing Act H.R 1628: American Health Care Act S. 872 / H.R. 1955: Rural Hospital Access Act S. 377: Medicare Ambulance Access, Fraud Prevention and Reform Act H.R. 1156: Patient Access to Higher Quality Health Care Act of 2017 H.R. 2: Medicare Access and CHIP Reauthorization Act of 2016 H.R. 1628 Better Care Reconciliation Act (BCRA) H.R. 4392 To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes. The Senate Committee on Health, Education, Labor and Pensions (HELP) June 26 passed the Lower Health Care Costs Act of 2019 (S.1895) Congress should act now to delay the Medicaid DSH cuts that are scheduled to go into effect Nov. 22. The Coronavirus Aid, Relief, and Economic Security (CARES) Act.

H.R. 1628 - CBD Product Safety and Standardization Act of 2023 H.R. 1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023 H.R. 4849 - Hemp Access and Consumer Safety Act S. 2451 - Hemp Access and Consumer Safety Act

Client expense: Not reported · Firm income: Not reported

H.R. 1628, H.R. 1629, S. 2451, Regulation of CBD as dietary supplement and food additive, 2023 Farm Bill

Client expense: Not reported · Firm income: $80,000

Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

Issues related to dietary supplements H.R. 1629, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023 H.R. 1628 , the CBD Product Safety and Standardization Act of 2023 FDA Reorganization

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1628 - CBD Product Safety and Standardization Act of 2023 H.R. 1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023 H.R. 4849 - Hemp Access and Consumer Safety Act S. 2451 - Hemp Access and Consumer Safety Act

Client expense: Not reported · Firm income: $50,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

H.R. 1628, CBD Product Safety and Standardization Act of 2023.

Client expense: $250,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1628 - CBD Product Safety and Standardization Act of 2023; all provisions of the bill HR 1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023; all provisions of the bill

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

Farm Bill of 2024, National Organic Program related issues Regulatory enforcement of dietary supplements, Mandatory product registration issues Cosmetics Regulatory Reform, Implementation related issues Monitor the following: Hemp-Derived Cannabidiol (CBD) regulations H.R.1629, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023, Entirety H.R.1628, To authorize the regulation of interstate commerce with respect to food containing cannabidiol derived from hemp, and for other purposes, Entirety Food Safety regulation related issues

Client expense: Not reported · Firm income: $20,000

Government targets: SENATE

Medicare and Medicaid Programs: Minimum Staffing Standards for Long-Term Care Facilities and Medicaid Institutional Payment Transparency Reporting (CMS 3442-P) ARPA American Rescue Act Plan Funding OSHA Covid-19 Health Care Emergency Temporary Standard (ETS) Bill That Extends Moratorium on 2% Medicare Sequester Cuts Through End of 2021 Healthcare Price Transparency Rules for Hospitals 340B Medicare DSH Medicare Physician Payment (MACRA) H.R. 365 The Primary Care Enhancement Act S. 898/H.R. 2141 Conrad State 30 and Physician Access Reauthorization Act S. 1130 Rural Emergency Acute Care Hospital (REACH) Act S. 257 / H.R. 1611: Protecting Access to Rural Therapy Services Act S. 258 / H.R. 169: Critical Access Hospital Relief Act of 2015 H.R. 672 / S. 607: Rural Community Hospital Demonstration Extension Act of 2015 S. 1135: Hospital Payment Fairness Act H.R. 1479: Repeal of the Obamacare Bay State Boondoggle Act S. 1648: Rural Emergency Acute Care Hospital Act H.R. 3225: Save Rural Hospitals Act H.R. 1343 / S. 688: Establishing Beneficiary Equity in the Hospital Readmission Program Act S. 1148 / H.R. 2124: Resident Physician Shortage Reduction Act S. 2484 / H.R. 4442: CONNECT for Health Act H.R. 2156: Medicare Audit Improvement Act H.R. 5164: Rural Hospital Regulatory Relief Act S. 3435: Craig Thomas Rural Hospital and Provider Equity Act of 2016 H.R. 5406: Helping Ensure Accountability, Leadership, and Trust in Tribal Healthcare Act H.R. 34: 21st Century Cures Act H.R. 3298: Medicare Post-Acute Care Value-Based Purchasing Act H.R 1628: American Health Care Act S. 872 / H.R. 1955: Rural Hospital Access Act S. 377: Medicare Ambulance Access, Fraud Prevention and Reform Act H.R. 1156: Patient Access to Higher Quality Health Care Act of 2017 H.R. 2: Medicare Access and CHIP Reauthorization Act of 2016 H.R. 1628 Better Care Reconciliation Act (BCRA) H.R. 4392 To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes. The Senate Committee on Health, Education, Labor and Pensions (HELP) June 26 passed the Lower Health Care Costs Act of 2019 (S.1895) Congress should act now to delay the Medicaid DSH cuts that are scheduled to go into effect Nov. 22. The Coronavirus Aid, Relief, and Economic Security (CARES) Act.

H.R. 1628 - CBD Product Safety and Standardization Act of 2023 H.R. 1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023

Client expense: Not reported · Firm income: $40,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

FDA regulations and legislation affecting dietary supplements, medical foods and other natural products; regulations and legislation related to foods and dietary supplements containing CBD; Coronavirus impact and response; H.R.1629, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023; H.R.1628, CBD Product Safety and Standardization Act of 2023.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1628, CBD Product Safety and Standardization Act of 2023.

Client expense: $240,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1628 - CBD Product Safety and Standardization Act of 2023; all provisions of the bill HR 1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023; all provisions of the bill

Client expense: $20,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

Issues related to dietary supplements H.R. 1629, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023 H.R. 1628 , the CBD Product Safety and Standardization Act of 2023 FDA Reorganization

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Farm Bill of 2024, National Organic Program related issues Hemp-Derived Cannabidiol (CBD) regulations H.R.1629, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023, Entirety H.R.1628, To authorize the regulation of interstate commerce with respect to food containing cannabidiol derived from hemp, and for other purposes, Entirety Regulatory enforcement of dietary supplements, Mandatory product registration issues Food Safety regulation related issues Cosmetics Regulatory Reform, Implementation related issues

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare and Medicaid Programs: Minimum Staffing Standards for Long-Term Care Facilities and Medicaid Institutional Payment Transparency Reporting (CMS 3442-P) ARPA American Rescue Act Plan Funding OSHA Covid-19 Health Care Emergency Temporary Standard (ETS) Bill That Extends Moratorium on 2% Medicare Sequester Cuts Through End of 2021 Healthcare Price Transparency Rules for Hospitals 340B Medicare DSH Medicare Physician Payment (MACRA) H.R. 365 The Primary Care Enhancement Act S. 898/H.R. 2141 Conrad State 30 and Physician Access Reauthorization Act S. 1130 Rural Emergency Acute Care Hospital (REACH) Act S. 257 / H.R. 1611: Protecting Access to Rural Therapy Services Act S. 258 / H.R. 169: Critical Access Hospital Relief Act of 2015 H.R. 672 / S. 607: Rural Community Hospital Demonstration Extension Act of 2015 S. 1135: Hospital Payment Fairness Act H.R. 1479: Repeal of the Obamacare Bay State Boondoggle Act S. 1648: Rural Emergency Acute Care Hospital Act H.R. 3225: Save Rural Hospitals Act H.R. 1343 / S. 688: Establishing Beneficiary Equity in the Hospital Readmission Program Act S. 1148 / H.R. 2124: Resident Physician Shortage Reduction Act S. 2484 / H.R. 4442: CONNECT for Health Act H.R. 2156: Medicare Audit Improvement Act H.R. 5164: Rural Hospital Regulatory Relief Act S. 3435: Craig Thomas Rural Hospital and Provider Equity Act of 2016 H.R. 5406: Helping Ensure Accountability, Leadership, and Trust in Tribal Healthcare Act H.R. 34: 21st Century Cures Act H.R. 3298: Medicare Post-Acute Care Value-Based Purchasing Act H.R 1628: American Health Care Act S. 872 / H.R. 1955: Rural Hospital Access Act S. 377: Medicare Ambulance Access, Fraud Prevention and Reform Act H.R. 1156: Patient Access to Higher Quality Health Care Act of 2017 H.R. 2: Medicare Access and CHIP Reauthorization Act of 2016 H.R. 1628 Better Care Reconciliation Act (BCRA) H.R. 4392 To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes. The Senate Committee on Health, Education, Labor and Pensions (HELP) June 26 passed the Lower Health Care Costs Act of 2019 (S.1895) Congress should act now to delay the Medicaid DSH cuts that are scheduled to go into effect Nov. 22. The Coronavirus Aid, Relief, and Economic Security (CARES) Act.

H.R. 1628, H.R. 1629, S. 2451, Regulation of CBD as dietary supplement and food additive, 2023 Farm Bill

Client expense: Not reported · Firm income: $80,000

Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

FDA regulations and legislation affecting dietary supplements, medical foods and other natural products; regulations and legislation related to foods and dietary supplements containing CBD; Coronavirus impact and response; H.R.1629, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023; H.R.1628, CBD Product Safety and Standardization Act of 2023.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1628, CBD Product Safety and Standardization Act of 2023. Issues related to supply chain disruptions in the beer industry.

Client expense: $500,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

USDA, National Organic Program related issues Monitor the following: Hemp-Derived Cannabidiol (CBD) regulations H.R.1629, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023, Entirety H.R.1628, To authorize the regulation of interstate commerce with respect to food containing cannabidiol derived from hemp, and for other purposes, Entirety Regulatory enforcement of dietary supplements, Mandatory product registration issues Food Safety regulation related issues Cosmetics Regulatory Reform, Implementation related issues

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to dietary supplements H.R. 1629, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023 H.R. 1628 , the CBD Product Safety and Standardization Act of 2023

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1628 - CBD Product Safety and Standardization Act of 2023; all provisions of the bill HR 1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023; all provisions of the bill

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues affecting the hemp and CBD industries. H.R. 1628, CBD Product Safety and Standardization Act of 2023 and H.R. 1629, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1628 - CBD Product Safety and Standardization Act of 2023 H.R. 1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023

Client expense: Not reported · Firm income: $30,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

H.R. 1628, H.R. 1629, Regulation of CBD as dietary supplement and food additive, 2023 Farm Bill

Client expense: Not reported · Firm income: $80,000

Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

ARPA American Rescue Act Plan Funding OSHA Covid-19 Health Care Emergency Temporary Standard (ETS) Bill That Extends Moratorium on 2% Medicare Sequester Cuts Through End of 2021 Healthcare Price Transparency Rules for Hospitals 340B Medicare DSH Medicare Physician Payment (MACRA) H.R. 365 The Primary Care Enhancement Act S. 898/H.R. 2141 Conrad State 30 and Physician Access Reauthorization Act S. 1130 Rural Emergency Acute Care Hospital (REACH) Act S. 257 / H.R. 1611: Protecting Access to Rural Therapy Services Act S. 258 / H.R. 169: Critical Access Hospital Relief Act of 2015 H.R. 672 / S. 607: Rural Community Hospital Demonstration Extension Act of 2015 S. 1135: Hospital Payment Fairness Act H.R. 1479: Repeal of the Obamacare Bay State Boondoggle Act S. 1648: Rural Emergency Acute Care Hospital Act H.R. 3225: Save Rural Hospitals Act H.R. 1343 / S. 688: Establishing Beneficiary Equity in the Hospital Readmission Program Act S. 1148 / H.R. 2124: Resident Physician Shortage Reduction Act S. 2484 / H.R. 4442: CONNECT for Health Act H.R. 2156: Medicare Audit Improvement Act H.R. 5164: Rural Hospital Regulatory Relief Act S. 3435: Craig Thomas Rural Hospital and Provider Equity Act of 2016 H.R. 5406: Helping Ensure Accountability, Leadership, and Trust in Tribal Healthcare Act H.R. 34: 21st Century Cures Act H.R. 3298: Medicare Post-Acute Care Value-Based Purchasing Act H.R 1628: American Health Care Act S. 872 / H.R. 1955: Rural Hospital Access Act S. 377: Medicare Ambulance Access, Fraud Prevention and Reform Act H.R. 1156: Patient Access to Higher Quality Health Care Act of 2017 H.R. 2: Medicare Access and CHIP Reauthorization Act of 2016 H.R. 1628 Better Care Reconciliation Act (BCRA) H.R. 4392 To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes. The Senate Committee on Health, Education, Labor and Pensions (HELP) June 26 passed the Lower Health Care Costs Act of 2019 (S.1895) Congress should act now to delay the Medicaid DSH cuts that are scheduled to go into effect Nov. 22. The Coronavirus Aid, Relief, and Economic Security (CARES) Act.

FDA regulations and legislation affecting dietary supplements, medical foods and other natural products; regulations and legislation related to foods and dietary supplements containing CBD; Coronavirus impact and response; H.R.1629, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023; H.R.1628, CBD Product Safety and Standardization Act of 2023.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE